REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/11/2026
Back to search
Official data from USPTO
POLYPROX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
POLYPROX
ST13
US500000079281280Class
1, 5, 42, 44
Filing
79281280
Registration
6344063
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/12/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
01/30/2020
Registration date
05/11/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/11/2021
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
LEASER, ANDREW C
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
L. I. (pessoa física)
PolyProx Therapeutics Ltd
Representatives
Steven A. Abreu Sunstein LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalschemical compounds and biologic compounds for use in industry and science; chemicalschemical compounds and biologic compounds for use in industry and scienceother than for medical or veterinary use; chemicalschemical compounds and biologic compounds for scientificlaboratory or research purposesin particular for use in the manufacture of pharmaceuticals and drugs for the treatment of cancerincluding lungcolorectal and pancreatic cancers
Class 5
Pharmaceuticalsdrugs and pharmaceutical preparations for the treatment of cancersneurological diseasesmetabolic diseasescardiovascular diseasesautoimmune and inflammatory diseases; pharmaceuticalsdrugs and pharmaceutical preparations for the treatment of cancerincluding lungcolorectal and pancreatic cancers
Class 42
Scientific and technological servicesscientific researchanalysisdesign and testing in the field of pharmaceuticalsdrugs and pharmaceutical preparations; drug discovery and drug development services; conducting or providing research and development services for others in the field of pharmaceuticalsdrugs and pharmaceutical preparations for the treatment of cancerincluding lungcolorectal and pancreatic cancers
Class 44
Medical services; medical services connected with the treatment of cancerincluding lungcolorectal and pancreatic cancers
Publications
History of USPTO decisions and trademark events.
27 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/20/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2021
FIMP
FINAL DISPOSITION PROCESSED
08/25/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/23/2021
PUBO
PUBLISHED FOR OPPOSITION
02/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
02/20/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2020
RFNT
REFUSAL PROCESSED BY IB
05/22/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/05/2020
RFRR
REFUSAL PROCESSED BY MPU
05/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/22/2020
CNRT
NON-FINAL ACTION WRITTEN
04/21/2020
DOCK
ASSIGNED TO EXAMINER
04/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/19/2020
Continuous trademark protection
Get notified about every new filing that threatens POLYPROX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.